Today: 23 April 2026
IMI share price slips in London as rate-cut bets build ahead of March results
17 February 2026
1 min read

IMI share price slips in London as rate-cut bets build ahead of March results

London, Feb 17, 2026, 09:22 GMT — Regular session underway.

  • IMI slipped 0.35% to 2,810p during the London morning session.
  • Traders are watching for UK inflation numbers on Wednesday, with IMI’s results landing March 6.
  • Sterling dropped as softer UK labour numbers brought BoE rate cut bets back into focus.

IMI plc shares edged down 0.35% to 2,810 pence as of 0906 GMT on Tuesday. Investors are taking positions ahead of the British engineer’s full-year earnings, which are due out March 6. The company supplies fluid- and motion-control components for energy, automation, and healthcare.

The shares slipped after UK labor figures landed, with the data pointing to higher joblessness and softer wage growth—enough to send sterling down and prompt bets on more Bank of England cuts. “This is yet another soft labour market report,” said Luke Bartholomew, deputy chief economist at Aberdeen. He noted the sluggishness in jobs “continuing to pull down on wage growth.” Reuters

Focus shifts to the UK inflation print, set for release by the Office for National Statistics at 0700 GMT on Wednesday. Markets are eyeing the January consumer price index, due Feb. 18, for clues on the pace and depth of possible rate cuts.

IMI wrapped up Monday at 2,820 pence, then bounced between 2,800 and 2,836 pence early Tuesday, according to MarketScreener. Shares have slipped around 1.5% in the last five sessions, but they’re still up about 13% this year.

With shares running up, what the company says about March is just as critical as the results themselves. When expectations are baked in, even a hint of shakiness in the outlook can hit a stock priced for consistent performance.

Order flows, margins, and cash generation are top of mind for investors, along with any signals about what customers are doing as the cycle shifts. Usually, it’s the first deep dive from management into 2026 demand that really stirs the stock.

Sterling’s decline sends a muddled message to exporters. Converted into pounds, foreign revenue gets a boost; yet higher import bills and pricing headaches come with the territory.

Still, inflation has a way of upending rate expectations without warning. If Wednesday’s CPI numbers come in hot—or if March 6 brings a cautious tone—this rally could quickly face pressure.

Stock Market Today

  • Jim Cramer Eyes More Procter & Gamble Shares If Price Dips Below $140
    April 23, 2026, 1:10 PM EDT. On Thursday, Jim Cramer highlighted a market rotation from software to hardware as ServiceNow shares fell 17% post-earnings despite beating forecasts. Chip designer Arm led the hardware rally, surging 6% to record highs, though Cramer expressed concern over its CEO's expanded role at SoftBank. Investor attention turns to Procter & Gamble, which rose over 1% ahead of Friday's earnings. Cramer said he plans to "buy more" shares if the price falls below $140, praising new CEO Shailesh Jejurikar's international expertise. Analysts expect modest earnings per share growth near 1% and organic revenue growth below 2%, with eyes on cost pressures from higher resin prices, a packaging material derived from oil.

Latest article

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

23 April 2026
IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

23 April 2026
Hims & Hers Health said Thursday its providers can now send prescriptions for Eli Lilly’s Zepbound and Foundayo to LillyDirect, expanding branded obesity drug options on its platform. The move follows a similar deal with Novo Nordisk in March. Hims listed Foundayo from $149 a month and Zepbound from $299. The company previously stopped advertising compounded GLP-1s amid tighter U.S. regulations.
Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

23 April 2026
Greg Abel now controls about 94% of Berkshire Hathaway’s $300 billion stock portfolio after Todd Combs’ departure, consolidating authority more than Warren Buffett had planned. Abel has kept major U.S. holdings largely intact but increased investments in Japanese firms, including a new $1.8 billion stake in Tokio Marine. Recent portfolio trims, such as Apple and Amazon, reflect Buffett’s last quarter in charge.
Rio Tinto stock in focus before London open as results near after Simandou death
Previous Story

Rio Tinto stock in focus before London open as results near after Simandou death

Northern Star shares tick up with gold stocks as traders eye US inflation data
Next Story

Northern Star shares tick up with gold stocks as traders eye US inflation data

Go toTop